BRAF mutant/MSS cancers have been found to have a comparably high rate of TP53 mutation as the BRAF wild-type cancers, whereas BRAF mutant/MSI were confirmed to have a low rate of mutation [44]. The gene discussed is TP53; the disease is cancer.